Exchange: NASDAQ·Updated 02:27 PM EDT
JBIO logo

JBIO Jade Biosciences Inc

$19.93
$0.03
(0.15%)
Today
Reported EarningsAug 10
Mkt Cap$1.27B
Vol417,066.00

About JBIO

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
46

Neutral Sentiment

How do you feel about JBIO?

Advertisement|Remove ads.